ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
Novavax Inc

Novavax Inc (NVAX)

8,745
-0,025
( -0,29% )
Mis à jour : 17:58:22

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

Dernier
8,745
Prix Achat
8,74
Prix Vente
8,75
Volume échangé
897 692
8,65 Fourchette du Jour 8,80
3,5324 Plage de 52 semaines 23,8599
Cap du marché
Clôture Veille
8,77
Ouverture
8,78
Dernière Transaction
2
@
8.745
Dernière heure de transaction
17:58:31
Volume financier
US$ 7 839 617
VWAP
8,7331
Volume moyen (3 m)
6 232 438
Actions en circulation
160 184 994
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-2,59
Bénéfice par action (BPA)
-3,4
Chiffre d'affairess
983,71M
Bénéfice net
-545,06M

À propos de Novavax Inc

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to res... Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. Novavax develops product candidates geared toward all age demographics of the general population. Show more

Secteur
Biological Pds,ex Diagnstics
Industrie
Biological Pds,ex Diagnstics
Site Web
Siège social
Wilmington, Delaware, USA
Fondé
-
Novavax Inc est coté dans le secteur Biological Pds,ex Diagnstics de la NASDAQ avec le ticker NVAX. Le dernier cours de clôture d'Novavax était de US$8,77. Au cours de la dernière année, les actions de Novavax ont été négociées dans une fourchette de prix de US$ 3,5324 à US$ 23,8599.

Novavax compte actuellement 160 184 994 actions en circulation. La capitalisation boursière d'Novavax est de US$1,40 milliard. Novavax a un ratio cours/bénéfice (ratio PE) de -2.59.

NVAX Dernières nouvelles

Novavax Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4)

Novavax Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4) PR Newswire GAITHERSBURG, Md., Nov. 15, 2024 GAITHERSBURG, Md., Nov. 15, 2024 /PRNewswire/ -- Novavax, Inc...

Novavax to Participate in Jefferies London Healthcare Conference

Novavax to Participate in Jefferies London Healthcare Conference PR Newswire GAITHERSBURG, Md., Nov. 13, 2024 GAITHERSBURG, Md., Nov. 13, 2024 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a...

Novavax Reports Third Quarter 2024 Financial Results and Operational Highlights

Novavax Reports Third Quarter 2024 Financial Results and Operational Highlights PR Newswire GAITHERSBURG, Md., Nov. 12, 2024 U.S. FDA removes clinical hold on Investigational New Drug application...

U.S. FDA Removes Clinical Hold on Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Phase 3 Trial

U.S. FDA Removes Clinical Hold on Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Phase 3 Trial PR Newswire GAITHERSBURG, Md., Nov. 11, 2024 GAITHERSBURG, Md., Nov. 11, 2024...

Novavax to Host Conference Call to Discuss Third Quarter 2024 Financial Results and Operational Highlights on November 12, 2024

Novavax to Host Conference Call to Discuss Third Quarter 2024 Financial Results and Operational Highlights on November 12, 2024 PR Newswire GAITHERSBURG, Md., Nov. 4, 2024 GAITHERSBURG, Md., Nov...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.485-5.254604550389.239.288.529867318.71126759CS
4-0.255-2.83333333333910.396.8156149098.37389797CS
12-4.005-31.411764705912.7515.226.81623243810.87859065CS
26-6.255-41.71523.85996.81793203313.48728316CS
523.22558.42391304355.5223.85993.5324946010310.30240135CS
156-160.255-94.825443787169236.53.5324752418723.58103101CS
2603.62570.800781255.12331.53883.5324680825353.86838467CS

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
CTNTCheetah Net Supply Chain Service Inc
US$ 5,07
(171,12%)
100,77M
ZJKZJK Industrial Company Ltd
US$ 14,40
(127,13%)
14,18M
CTORCitius Oncology Inc
US$ 1,65
(61,76%)
92,34M
JANXJanux Therapeutics Inc
US$ 62,965
(56,71%)
4,5M
GWAVGreenwave Technology Solutions Inc
US$ 0,5676
(55,51%)
291,95M
REVBRevelation Biosciences Inc
US$ 0,5376
(-43,40%)
2,7M
OMEXOdyssey Marine Exploration Inc
US$ 0,47415
(-36,37%)
2,9M
GELSGelteq Ltd
US$ 2,6001
(-31,94%)
201,07k
STSSSharps Technology Inc
US$ 2,35
(-29,93%)
174,55k
SNTISenti Biosciences Inc
US$ 7,08
(-29,20%)
5,38M
GWAVGreenwave Technology Solutions Inc
US$ 0,5675
(55,48%)
291,95M
SMCISuper Micro Computer Inc
US$ 41,1873
(-1,94%)
146,15M
CTNTCheetah Net Supply Chain Service Inc
US$ 5,07
(171,12%)
100,77M
CHRSCoherus BioSciences Inc
US$ 1,98
(44,53%)
94,56M
CTORCitius Oncology Inc
US$ 1,65
(61,76%)
92,34M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées